Latest Breaking News On - Navidea manocept - Page 1 : comparemela.com

Navidea Biopharmaceuticals, Inc Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations

Navidea Biopharmaceuticals, Inc Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNavidea manoceptTheodore gerbickExchange commissionNavidea biopharmaceuticals incExchange act the deregistrationSecurities exchangeNavidea biopharmaceuticalsSecurities exchange actExchange actSecurities actAnnual report

Navidea Biopharmaceuticals, Inc and Capital Royalty Partners II, L P Enter Binding Settlement Agreement and Mutual Release

Navidea Biopharmaceuticals, Inc and Capital Royalty Partners II, L P Enter Binding Settlement Agreement and Mutual Release
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJohnk scott jrNavidea manoceptSeriesj preferred stock of the companyNavidea biopharmaceuticals incSecurities exchangeCompany board of directorsCapital royalty partnersBinding settlement agreementMutual release alignsVice chairLoan agreementSeriesg preferred stockSeriesi preferred stockSeriesj preferred stockChief financial

Navidea Biopharmaceuticals, Inc Announces NYSE American s Decision to Suspend Trading In Its Common Stock

Navidea Biopharmaceuticals, Inc Announces NYSE American s Decision to Suspend Trading In Its Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTheodore gerbickNavidea manoceptExchange commissionSecurities exchangeCompany of the panelNavidea biopharmaceuticals incListings qualifications panelChief financialSecurities actSecurities exchange actAnnual reportNavidea biopharmaceuticals

Navidea Biopharmaceuticals, Inc NAVB Requests Oral Hearing With NYSE Hearing Panel

Following the Company’s Fix, Fund, Propel approach, Navidea formally submitted a request for an oral hearing with New York Stock Exchange American Hearing Panel to appeal potential delisting of. -Today at 09:30 am- MarketScreener

United statesNavidea manoceptCompany boardNavidea biopharmaceuticals incHearing panelExchange hearing panelAmerican hearing panelYork stock exchangeAmerican exchangeSecurities exchangeNavidea biopharmaceuticalsNew york stock exchangeChief financialDelisting appealSecurities actSecurities exchange act

Navidea Biopharmaceuticals, Inc Presses Ahead, Embraces Opportunities

Following the Company’s Fix, Fund, Propel approach, Navidea continues forward-focus to advance innovative technology to market while intending to appeal the potential delisting of its stock from.

United statesNavidea manoceptJill bieker stefanelliSimon alder blackburnDanaj mossJosh wilsonCardinal healthStrategic partnership initiativeSecurities exchangeFix fundCompany forwardCompany fixClinical researchCompany board of directorsNavidea biopharmaceuticals incCompany board